【药明生物：杭州基地15000升原液生产线完成首个商业化项目PPQ生产】金十数据4月17日讯，药明生物(02269.HK)宣布，其位于杭州基地的生物药原液二十厂（MFG20）第二条原液生产线的三组5000升一次性生物反应器（SUB），以100%成功率完成首个商业化项目工艺性能确认（PPQ）生产。作为公司目前最大的已投产一次性生物反应器，其结合同厂配备的四组2000升一次性技术生产线，推动工厂总产能由8000升跃升至23000升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.